Work

A multicentric survey on antimicrobial use and hospital acquired infections among patients admitted in tertiary care centers in India

Year: 2025

Type: article

Abstract: Discussion: The study highlights the profound effects of drug unavailability of Anti-HIV, Anti-TB and Anti-malarial drugs on global health.It reveals how unavailability contributes to therapy failure and the emergence of resistance, limiting treatment options.The gaps in understanding the economic and ecological impacts of unavailability are alarming.Lack of transparency on causes and the influence of supply and demand worsen the situation.Governments and regulatory bodies should mandate reporting and transparency to address these issues effectively.Conclusions: Concerted effort is needed to evaluate the impact of these drug unavailability on health outcomes, and cost implications including due to changes in available alternative agents and the implications of these changes in demand on supply chains.Interventions to address unavailability should be studied to determine cost and impact.Additionally, it is crucial to devise strategies that capitalize on the manufacturing capacity in LMICs to effectively tackle this issue.

Source: International Journal of Infectious Diseases

DOI: 10.1016/j.ijid.2024.107471

Authors: Prof Nusrat Shafiq, Dr. Samiksha Bhattacharjee, Dr. Ashish Kumar Kakkar, Mr. Chakrant Mothsara, Dr. Prasan Kumar Panda, Dr. Naveen Murali

Institutions: Post Graduate Institute of Medical Education and Research, All India Institute of Medical Sciences

Language: English

Topic: Antibiotic Use and Resistance

Subfield: Applied Microbiology and Biotechnology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,900